"early ART" - given within 14 days of starting acute OI treatment	"deferred ART" - given after acute OI treatment is completed	AIDS progression/death	18149	18544	There was no statistically significant difference in the ordered 3 category primary endpoint at 48 weeks: AIDS progression/death in 20 (14%) vs. 34 (24%); 54 (38%) vs. 44 (31%) had no progression or death but viral load ≥50 copies/ml; and 67 (48%) vs. 63 (45%) had no progression or death and viral load of <50 copies/ml at week 48 in the early versus the deferred arms, respectively (p = 0.22).
"early ART" - given within 14 days of starting acute OI treatment	"deferred ART" - given after acute OI treatment is completed	progression or death but viral load ≥50 copies/ml; progression or death and viral load of <50 copies/ml at week 48	18149	18544	There was no statistically significant difference in the ordered 3 category primary endpoint at 48 weeks: AIDS progression/death in 20 (14%) vs. 34 (24%); 54 (38%) vs. 44 (31%) had no progression or death but viral load ≥50 copies/ml; and 67 (48%) vs. 63 (45%) had no progression or death and viral load of <50 copies/ml at week 48 in the early versus the deferred arms, respectively (p = 0.22).
"early ART" - given within 14 days of starting acute OI treatment	"deferred ART" - given after acute OI treatment is completed	progression or death but viral load ≥50 copies/ml; progression or death and viral load of <50 copies/ml at week 48	18147	18544	) There was no statistically significant difference in the ordered 3 category primary endpoint at 48 weeks: AIDS progression/death in 20 (14%) vs. 34 (24%); 54 (38%) vs. 44 (31%) had no progression or death but viral load ≥50 copies/ml; and 67 (48%) vs. 63 (45%) had no progression or death and viral load of <50 copies/ml at week 48 in the early versus the deferred arms, respectively (p = 0.22).
"early ART" - given within 14 days of starting acute OI treatment	"deferred ART" - given after acute OI treatment is completed	The time to a CD4+ count >50 cells/mm3	23043	23281	The time to a CD4+ count >50 cells/mm3 was 4.0 weeks versus 8.6 weeks and time to CD4+ count greater than 100 cells/mm3 was 4.3 weeks vs. 12.0 weeks in the early-versus-deferred arm, respectively (p<0.001 for both comparisons). (Figure 5)
"early ART" - given within 14 days of starting acute OI treatment	"deferred ART" - given after acute OI treatment is completed	AIDS progression/death	1230	1366	The difference in the primary endpoint did not reach statistical significance: AIDS progression/death was seen in 20 (14%) vs. 34 (24%);
"early ART" - given within 14 days of starting acute OI treatment	"deferred ART" - given after acute OI treatment is completed	The time to a CD4+ count >50 cells/mm3	1774	1857	The early ART had shorter time to achieving a CD4 count above 50 cells/mL (p<0.001)
